arrow
J

Joe-Elie Salem

pitie-salpetriere hospital
H指数:63
被引数:2.0万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

A gut microbiome-kidney-heart axis predictive of future cardiovascular diseases

一个预测未来心血管疾病的肠道微生物组-肾脏-心脏轴

2026-03-050
OAAI
Prominent mediatory role of gut microbiome in the effect of lifestyle on host metabolic phenotypes

肠道菌群在生活方式对宿主代谢表型影响中的中介作用

2025-12-310
PRE
Risk of QTc prolongation, and major cardiovascular adverse events associated with CDK4/6 inhibitors in hormone receptor-positive HER2-negative breast cancer – A systematic review and meta-analysis

CDK4/6抑制剂在激素受体阳性、HER2阴性乳腺癌中导致QTc间期延长及主要心血管不良事件的风险——一项系统评价和荟萃分析

2025-12-160
PRE
Impact of Antihypertensive Treatment on Outcomes of Adjuvant Bevacizumab for Ovarian Cancer (IATRO), Results from a Nationwide Emulated Clinical Trial

抗高血压治疗对卵巢癌辅助贝伐珠单抗结局的影响(IATRO):一项全国模拟临床试验的结果

2025-09-260
OAAI
Immune checkpoint inhibitor-associated myocarditis: a novel risk score

免疫检查点抑制剂相关心肌炎:一种新型风险评分

2025-06-180
PRE
Metabolic dysfunction-associated steatotic liver disease (MASLD) biomarkers and progression of lower limb arterial calcification in patients with type 2 diabetes: a prospective cohort study

代谢功能障碍相关脂肪性肝病(MASLD)生物标志物与2型糖尿病患者的下肢动脉钙化进展:一项前瞻性队列研究

2025-04-230
OA
Features of myositis and myasthenia gravis in patients treated with immune checkpoint inhibitors: a multicentric, retrospective cohort study

免疫检查点抑制剂治疗患者的皮肌炎和多发性硬化特征:一项多中心回顾性队列研究

2025-03-014
PRE
Case Report: Immune checkpoint-inhibitor related myotoxicity monitoring using a comprehensive cardiothoracic MRI approach: insights from a clinical case

病例报告:使用全面的心胸MRI方法监测免疫检查点抑制剂相关肌毒性:来自临床病例的见解

2025-02-140
OA
Clinical correlates of lifetime and current comorbidity patterns in autoimmune and inflammatory diseases
2024-12-011
OA